Wings Therapeutics Wings Therapeutics is a biotechnology company engaged in the development of therapies for patients suffering from Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin blistering disease. | ||
Founding Date | Founding Date 2019 | Founding Date 2018 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Berkeley, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 5 | Employees 427% decrease |
Funding | ||
Latest funding round | Latest funding round $ 1.5m (about 7 years ago) | Latest funding round $ 80m (over 5 years ago) |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 113.5m |
Neuron23 is a biotechnology company that develops medicines for genetic disorders.
View company